ABSTRACT
Domestic and overseas studies onthe prominent eartreatment were reviewed and analyzed.Current progress of clinical therapy for prominent ear was summarized.The uniform clinical diagnosis and therapy of prominent earhave not been determined, due to its complicated and various therapeutic methods and unclear etiology. Reported therapies mainly include: (1)surgical therapy, which attains satisfactory therapeutic effect by adopting improved approaches, i. e. the combination of operations or the innovative methods based on Mustarde′s, Sterstrom′s and Converse′s surgical methods. (2)Non-surgical therapy, including ear splinting or molding, and laser-assisted cartilage reshaping(LACR). The non-surgical therapyisa hot research field, and is going to bepopularizedin the future.Research of etiology and non-surgical treatments may be helpful to provide abetter therapy strategy for prominent ear.
ABSTRACT
Se describe un caso de malaria congénita en paciente masculino de 16 días de edad, ingresado en emergencia pediátrica del Hospital Dr. J. M. Casal Ramos, Acarigua estado Portuguesa, con diagnóstico de sepsis neonatal tardía. La madre del menor, residente de área minera del estado Bolívar, refirió síndrome febril que comenzó el día previo al parto 09/07/2013 hasta el 23/07/2013, cuando se le diagnosticó malaria por Plasmodium vivax, iniciando tratamiento con cloroquina, siguiendo la pauta nacional de tratamientos antimaláricos de Venezuela. Durante la investigación epidemiológica de la madre, no se le tomó al niño muestra hemática para malaria, esto impidió detectar oportunamente su infección, lo que hubiera evitado efectos de la malaria sobre sus condiciones generales de salud. La fiebre en el niño se manifestó el 26/07/2013, y el 29/07/2013 se le tomó muestra hemática para malaria, después que durante el interrogatorio de la madre, para indagar antecedentes del niño, ella refirió recibir tratamiento antimalárico. Esta muestra hemática del niño resulto positiva a P. vivax, iniciando tratamiento con cloroquina, según pautas oficiales. La situación presentada, obliga al personal de salud a establecer prioridades para diagnóstico de malaria, a todo febril de la consulta maternoinfantil, y evaluar la situación epidemiológica de la malaria en embarazadas de zonas endémicas, repercusión clínica en la madre y en el producto de la gestación. Debe extenderse la atención a embarazadas que residan o no en áreas endémicas, y que refieran visitas a zona endémica antes o después del embarazo.
A congenital malaria case by Plasmodium vivax is described in a 16 day old male newborn, admitted to Dr. J.M. Casal Ramos Hospital, Acarigua, Portuguesa state, he was initially diagnosed as a late neonatal sepsis. The boy's mother, who lives in the mining area of Bolivar state, referred febrile syndrome that began the day before the birth 09/07/2013 until 23/07/2013, when she was diagnosed with malaria by P. vivax, initiating treatment with chloroquine following the General treatment for malaria infections in Venezuela. It notes that in the epidemiological investigation of the mother, no Blood smears for malaria parasites was taken to the child; this prevented the timely detection of infection, which would have prevented effects of malaria on their general health. The fever began in the child on July 26, 2013 and the Blood smears for malaria parasites was taken on July 29, 2013, then during the interrogation of the mother to investigate background of the child, she referred to receive antimalarial treatment. The Blood smears for malaria parasites was indicative of malaria parasites P. vivax, initiating treatment with chloroquine, according to official guidelines. The reported situation obliges health personnel to prioritize malaria diagnosis in every child with fever in the infant-maternal ward and assess the epidemiological situation of malaria in pregnant women in endemic areas, and the clinical impact in mother and the new born.
ABSTRACT
Psychiatric management of patients with breast cancer, as well as women's emotional reactions to all phases of breast cancer, were reviewed. These patients face two major losses; one is the physical loss of part of the body and a threat to life, and the other is the loss of femininity. The patients are also likely to suffer from various psychiatric problems including anxiety and depression. Oncologists should be alert to each patient's emotional reactions and potential psychiatric problems, and if necessary, should refer them to a psychiatrist. A combination of psychotherapeutic, behavioural, and pharmacologic techniques is available for the care of patients with breast cancer. Psychotherapeutic modalities include individual therapy, family therapy, group therapy, and self-help treatment. The author divided individual therapy into general and specific treatment. General treatment deals with a crisis-intervention and cognitive-behavioral approach, whereas specific treatment deals with issues relevant to patients with breast cancer. Some of the therapeutic processes were illustrated in a case report. These guidelines will contribute to the relief and prevention of emotional suffering stemming from an encounter with the most common form of cancer in women. Also, proper and effective care for patients with breast cancer requires combined use of a variety of therapeutic modalities as well as a multi-disciplinary approach including psychiatric care.